SwanBio Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- SwanBio Therapeutics's estimated annual revenue is currently $4M per year.
- SwanBio Therapeutics's estimated revenue per employee is $77,500
- SwanBio Therapeutics's total funding is $52M.
Employee Data
- SwanBio Therapeutics has 52 Employees.
- SwanBio Therapeutics grew their employee count by -13% last year.
SwanBio Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | VP Tech Ops and Quality | Reveal Email/Phone |
3 | VP, Legal and Intellectual Property | Reveal Email/Phone |
4 | SVP Program Development | Reveal Email/Phone |
5 | Head Portfolio Development | Reveal Email/Phone |
6 | General Counsel & Head Intellectual Property | Reveal Email/Phone |
7 | Human Resources Director | Reveal Email/Phone |
8 | Director Clinical Operations | Reveal Email/Phone |
9 | Chief People Officer | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
SwanBio Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is SwanBio Therapeutics?
With offices in Philadephia and Boston, SwanBio Therapeutics is developing leading-edge therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by an unrelenting passion to solve difficult challenges, and a belief that meaningful discovery is borne of curiosity, collaboration, and compassion. Founded by proven industry leaders with a commitment to positively impacting the lives of people with neurological diseases, SwanBio merges clinical, scientific and drug commercialization expertise. To learn about career opportunities contact us at [email protected].
keywords:N/A$52M
Total Funding
52
Number of Employees
$4M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SwanBio Therapeutics News
SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...
SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...
SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...
SwanBio Therapeutics, a Bala Cynwyd, Pa.-based gene therapy company developing medicines to deliver clinical efficacy for the treatment of AMN and other neurological diseases, completed a $52m expanded Series A financing. Syncona Ltd. and Partners Innovation Fund made a $20m investment as part ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 55 | 2% | N/A |
#2 | $14.3M | 59 | -3% | N/A |
#3 | $8.5M | 63 | 37% | N/A |
#4 | $16.3M | 67 | 3% | N/A |
#5 | $13.8M | 73 | -4% | N/A |